Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment

1

Retinal vein occlusion (RVO) is a prevalent microvascular disease, with varying rates among ethnic groups and increasing incidence with age.
2

C-reactive protein (CRP) and albumin serve as acute phase reactants, indicating systemic inflammation and are linked to cardiovascular diseases.
3

The study aimed to evaluate the CRP/albumin ratio and systemic immune-inflammation index (SII) as inflammation markers in RVO patients.
4

Results showed that the CRP/albumin ratio was significantly higher in RVO patients compared to healthy controls, indicating its potential as a prognostic marker.
5

The optimal cut-off value of the CRP/albumin ratio for RVO estimation was determined to be 0.42, with 79% sensitivity and 55% specificity.

1